Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Nationwide Children's Hospital
Centre Oscar Lambret
Nationwide Children's Hospital
Washington University School of Medicine
University of Florida
Children's Oncology Group
Children's Oncology Group
Nationwide Children's Hospital
Eli Lilly and Company
M.D. Anderson Cancer Center
Children's Oncology Group
Nationwide Children's Hospital